Fluorine-18 molecular imaging

Fluorine-18 molecular imaging

DOPAVIEW / PADOVIEW

Advanced Accelerator Applications brand names for 6-fluoro-[18F]-L-DOPA, a DOPA analog

Neurology, Oncology

SmPC

France

• Notice of transparency (PDF 0.5 MB)
• Summary of product characteristics (PDF 0.4 MB)
• User information (PDF 0.3 MB)

Germany

• Technical information (PDF 0.2 MB)
• User Information (PDF 0.2 MB)

Italy

• Summary of product characteristics (PDF 0.2 MB)

Portugal

• Summary of product characteristics (PDF 0.3 MB)

Spain

• Technical information

Switzerland

• Professional information French (PDF 0.1 MB)
• Professional information German (PDF 0.1 MB)
• Professional information Italian (PDF 0.1 MB)

---

FLUOROCHOL / AAACHOLINE / CHOLSCAN

Advanced Accelerator Applications brand names for [18F]-choline (FCH)

Oncology

SmPC

France

• Notice of transparency (PDF 0.4 MB)
• Summary of product characteristics (PDF 0.2 MB)
• User information (PDF 0.2 MB)

Germany

• Technical information (PDF 0.2 MB)
• User Information (PDF 0.2 MB)

Italy

• Summary of product characteristics (PDF 0.2 MB)

Portugal

• Summary of product characteristics (PDF 0.3 MB)

Spain

• Technical information

Switzerland

• Professional information French (PDF 0.1 MB)
• Professional information German (PDF 0.1 MB)
• Professional information Italian (PDF 0.2 MB)

---

GLUSCAN / BARNASCAN

Advanced Accelerator Applications brand names for FDG (most widely used PET tracer)

Oncology, Cardiology, Neurology, Infectious and inflammatory diseases

SmPC

France

• Notice of transparency (PDF 0.1 MB)
• Summary of product characteristics (PDF 0.3 MB)
• User information (PDF 0.2 MB)

Germany

• Technical information (PDF 0.1 MB)
• User Information (PDF 0.2 MB)

Italy

• Summary of product characteristics (PDF 0.3 MB)

Portugal

• Summary of product characteristics (PDF 0.3 MB)
• User information (PDF 0.2 MB)

Spain

• Barnascan technical information
• Gluscan technical information

Switzerland

• Professional information on medicines for human use French (PDF 0.2 MB)
• Professional information on medicines for human use German (PDF 0.2 MB)
• Professional information on medicines for human use Italian (PDF 0.2 MB)

1. https://prod1.adacap.com/our-products/fluorine-18-molecular-imaging
2. https://prod1.adacap.com/sites/novartis_adacap/files/CT_DOPAVIEW.pdf
3. https://prod1.adacap.com/sites/novartis_adacap/files/2023_01_19_Master-SPC_Dopaview_FR.pdf
4. https://prod1.adacap.com/sites/novartis_adacap/files/2023_01_19_Master-PIL_Dopaview_FR.pdf
5. https://prod1.adacap.com/sites/novartis_adacap/files/Dopaview-FI-Dezember-2022.pdf
6. https://prod1.adacap.com/sites/novartis_adacap/files/Dopaview-GI-Dezember-2022-1.pdf
7. https://prod1.adacap.com/sites/novartis_adacap/files/PADOVIEW_RCP_JAN23-1.pdf
8. https://prod1.adacap.com/sites/novartis_adacap/files/RCM_Dopaview.pdf
9. https://cima.aemps.es/cima/dochtml/ft/83007/FT_83007.html
10. https://prod1.adacap.com/sites/novartis_adacap/files/AAADopaview_CH_RCP_FR_AIPS_190630.pdf
11. https://prod1.adacap.com/sites/novartis_adacap/files/AAADopaview_CH_RCP_DE_AIPS_190630.pdf
12. https://prod1.adacap.com/sites/novartis_adacap/files/AAADopaview_CH_RCP_IT_AIPS_190630.pdf
13. https://prod1.adacap.com/sites/novartis_adacap/files/CT_FLUOROCHOL.pdf
14. https://prod1.adacap.com/sites/novartis_adacap/files/SPC-Fluorochol-Feb-2024.pdf
15. https://prod1.adacap.com/sites/novartis_adacap/files/PIL-Fluorochol-Feb-2024.pdf
16. https://prod1.adacap.com/sites/novartis_adacap/files/Fluorochol-FI-Dezember-2022.pdf
17. https://prod1.adacap.com/sites/novartis_adacap/files/Fluorochol-GI-Dezember-2022-1.pdf
18. https://prod1.adacap.com/sites/novartis_adacap/files/CHOLSCAN_RCP_JAN23-2.pdf
19. https://prod1.adacap.com/sites/novartis_adacap/files/RCM_Cholview.pdf
20. https://cima.aemps.es/cima/dochtml/ft/82081/FT_82081.html
21. https://prod1.adacap.com/sites/novartis_adacap/files/AAACholine_CH_RCP_FR_AIPS_160912.pdf
22. https://prod1.adacap.com/sites/novartis_adacap/files/AAACholine_CH_RCP_DE_AIPS_160912.pdf
23. https://prod1.adacap.com/sites/novartis_adacap/files/it-aaacholine-222-mbq-ml-fluorometil.pdf
24. https://prod1.adacap.com/sites/novartis_adacap/files/CT_GLUSCAN.pdf
25. https://prod1.adacap.com/sites/novartis_adacap/files/SPC-Gluscan-April-2024.pdf
26. https://prod1.adacap.com/sites/novartis_adacap/files/PIL-Gluscan-April-2024.pdf
27. https://prod1.adacap.com/sites/novartis_adacap/files/Gluscan-FI-Dezember-2022.pdf
28. https://prod1.adacap.com/sites/novartis_adacap/files/Gluscan-GI-Dezember-2022-1.pdf
29. https://prod1.adacap.com/sites/novartis_adacap/files/GLUSCAN_RCP_JAN23-1.pdf
30. https://prod1.adacap.com/sites/novartis_adacap/files/RCM_Gluscan.pdf
31. https://prod1.adacap.com/sites/novartis_adacap/files/FI-Gluscan-April-2024.pdf
32. https://cima.aemps.es/cima/dochtml/ft/68016/FT_68016.html
33. https://cima.aemps.es/cima/pdfs/ft/81346/FT_81346.pdf
34. https://prod1.adacap.com/sites/novartis_adacap/files/GLUSCAN_CH_RCP_FR_AIPS_Vs11_191024_FR.pdf
35. https://prod1.adacap.com/sites/novartis_adacap/files/GLUSCAN_CH_RCP_DE_AIPS_Vs5_191024_DE.pdf
36. https://prod1.adacap.com/sites/novartis_adacap/files/GLUSCAN_CH_RCP_IT_AIPS_Vs4_191024_IT.pdf